66 results
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
proactively sought feedback from stockholders to understand key matters of interest as we continue to iterate our governance and compensation practices … including: Business strategy CEO and other executive leadership transitions 2023 say-on-pay results Corporate governance Compensation philosophy
S-3ASR
EX-1.2
VIR
Vir Biotechnology Inc
3 Nov 23
Automatic shelf registration
4:33pm
the Nasdaq shall have approved the Shares for listing, it will be in compliance with all applicable corporate governance requirements set forth